186 related articles for article (PubMed ID: 24992077)
1. Synthesis and antiproliferative activity of novobiocin analogues as potential hsp90 inhibitors.
Audisio D; Methy-Gonnot D; Radanyi C; Renoir JM; Denis S; Sauvage F; Vergnaud-Gauduchon J; Brion JD; Messaoudi S; Alami M
Eur J Med Chem; 2014 Aug; 83():498-507. PubMed ID: 24992077
[TBL] [Abstract][Full Text] [Related]
2. New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein 90.
Le Bras G; Radanyi C; Peyrat JF; Brion JD; Alami M; Marsaud V; Stella B; Renoir JM
J Med Chem; 2007 Nov; 50(24):6189-200. PubMed ID: 17979263
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novobiocin analogues as potential heat shock protein 90 inhibitors.
Gunaherath GM; Marron MT; Wijeratne EM; Whitesell L; Gunatilaka AA
Bioorg Med Chem; 2013 Sep; 21(17):5118-29. PubMed ID: 23859777
[TBL] [Abstract][Full Text] [Related]
4. Click chemistry to probe Hsp90: Synthesis and evaluation of a series of triazole-containing novobiocin analogues.
Peterson LB; Blagg BS
Bioorg Med Chem Lett; 2010 Jul; 20(13):3957-60. PubMed ID: 20570149
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors.
Kusuma BR; Khandelwal A; Gu W; Brown D; Liu W; Vielhauer G; Holzbeierlein J; Blagg BS
Bioorg Med Chem; 2014 Feb; 22(4):1441-9. PubMed ID: 24461493
[TBL] [Abstract][Full Text] [Related]
6. Novobiocin Analogs as Potential Anticancer Agents.
Dlugosz A; Janecka A
Mini Rev Med Chem; 2017; 17(9):728-733. PubMed ID: 28019639
[TBL] [Abstract][Full Text] [Related]
7. Novobiocin Analogues That Inhibit the MAPK Pathway.
Hall JA; Seedarala S; Zhao H; Garg G; Ghosh S; Blagg BS
J Med Chem; 2016 Feb; 59(3):925-33. PubMed ID: 26745854
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of arylated novobiocin analogs as Hsp90 inhibitors.
Kusuma BR; Duerfeldt AS; Blagg BS
Bioorg Med Chem Lett; 2011 Dec; 21(23):7170-4. PubMed ID: 22014546
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors.
Byrd KM; Subramanian C; Sanchez J; Motiwala HF; Liu W; Cohen MS; Holzbeierlein J; Blagg BS
Chemistry; 2016 May; 22(20):6921-31. PubMed ID: 27037933
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative and apoptotic activities of tosylcyclonovobiocic acids as potent heat shock protein 90 inhibitors in human cancer cells.
Radanyi C; Le Bras G; Marsaud V; Peyrat JF; Messaoudi S; Catelli MG; Brion JD; Alami M; Renoir JM
Cancer Lett; 2009 Feb; 274(1):88-94. PubMed ID: 18842335
[TBL] [Abstract][Full Text] [Related]
11. Discovery and biological activity of 6BrCaQ as an inhibitor of the Hsp90 protein folding machinery.
Audisio D; Messaoudi S; Cegielkowski L; Peyrat JF; Brion JD; Methy-Gonnot D; Radanyi C; Renoir JM; Alami M
ChemMedChem; 2011 May; 6(5):804-15. PubMed ID: 21374821
[TBL] [Abstract][Full Text] [Related]
12. Hsp90 inhibitors identified from a library of novobiocin analogues.
Yu XM; Shen G; Neckers L; Blake H; Holzbeierlein J; Cronk B; Blagg BS
J Am Chem Soc; 2005 Sep; 127(37):12778-9. PubMed ID: 16159253
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of simplified denoviose-coumarins related to novobiocin as potent inhibitors of heat-shock protein 90 (hsp90).
Radanyi C; Le Bras G; Messaoudi S; Bouclier C; Peyrat JF; Brion JD; Marsaud V; Renoir JM; Alami M
Bioorg Med Chem Lett; 2008 Apr; 18(7):2495-8. PubMed ID: 18304811
[TBL] [Abstract][Full Text] [Related]
14. The synthesis and evaluation of flavone and isoflavone chimeras of novobiocin and derrubone.
Mays JR; Hill SA; Moyers JT; Blagg BS
Bioorg Med Chem; 2010 Jan; 18(1):249-66. PubMed ID: 19932969
[TBL] [Abstract][Full Text] [Related]
15. Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines.
Burlison JA; Avila C; Vielhauer G; Lubbers DJ; Holzbeierlein J; Blagg BS
J Org Chem; 2008 Mar; 73(6):2130-7. PubMed ID: 18293999
[TBL] [Abstract][Full Text] [Related]
16. Novobiocin-ferrocene conjugates possessing anticancer and antiplasmodial activity independent of HSP90 inhibition.
Mbaba M; de la Mare JA; Sterrenberg JN; Kajewole D; Maharaj S; Edkins AL; Isaacs M; Hoppe HC; Khanye SD
J Biol Inorg Chem; 2019 Mar; 24(2):139-149. PubMed ID: 30542925
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiproliferative activity of 6BrCaQ-TPP conjugates for targeting the mitochondrial heat shock protein TRAP1.
Mathieu C; Chamayou Q; Hyen Luong TT; Naud D; Mahuteau-Betzer F; Alami M; Fattal E; Messaoudi S; Vergnaud-Gauduchon J
Eur J Med Chem; 2022 Feb; 229():114052. PubMed ID: 34952432
[TBL] [Abstract][Full Text] [Related]
18. The design, synthesis, and evaluation of coumarin ring derivatives of the novobiocin scaffold that exhibit antiproliferative activity.
Donnelly AC; Mays JR; Burlison JA; Nelson JT; Vielhauer G; Holzbeierlein J; Blagg BS
J Org Chem; 2008 Nov; 73(22):8901-20. PubMed ID: 18939877
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors.
Zhao H; Garg G; Zhao J; Moroni E; Girgis A; Franco LS; Singh S; Colombo G; Blagg BS
Eur J Med Chem; 2015 Jan; 89():442-66. PubMed ID: 25462258
[TBL] [Abstract][Full Text] [Related]
20. Development of Phenyl Cyclohexylcarboxamides as a Novel Class of Hsp90 C-terminal Inhibitors.
Garg G; Forsberg LK; Zhao H; Blagg BSJ
Chemistry; 2017 Nov; 23(65):16574-16585. PubMed ID: 28940589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
